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Introduction
in the near future. Anticipating this, 
doctors have been providing notiﬁcation 
of communicable diseases directly to 
THL since 1 January 2009.
Overview 
Among respiratory infections, an 
extensive resistance to oseltamivir that 
has rapidly become more common in 
the inﬂuenza A, subtype H1N1 virus 
is causing concern. The increased 
resistance had no correlation with 
the amount of antiviral used, and the 
virulence of the resistant viruses is equal 
to that of those susceptible to antiviral 
drugs. The resistance has an effect on the 
possibility of using the medication to 
treat seasonal inﬂuenza and on the role 
of drugs in preparation for a possible 
pandemic. The development of this 
resistance provides more solid grounds 
for strengthening the administration 
of vaccinations to elderly people and 
to medical risk groups to bring the 
coverage to a reasonable European level 
and for reinforcing the recently started 
administration of inﬂuenza vaccination 
to children. That the number of 
whooping cough cases has remained low 
and there have been no cyclic epidemics 
as are typical of the disease indicates 
that the whooping cough vaccination 
programme that was updated this 
decade has reduced the incidence of the 
disease.
The number of campylobacter 
infections was one of the highest in the 
On 1 January 2009, The National Public 
Health Institute (KTL) and STAKES 
merged to form a new organisation, the 
National Institute for Welfare and Health 
(THL). This new institute has the same 
obligations and authority as KTL in 
the ﬁeld of surveillance and prevention 
of infectious diseases. The new 
organisation with its diverse resources 
offers increasingly better surveillance 
opportunities, for example, by utilising 
the national patient record systems that 
are under development. The prevention 
and control of infectious diseases 
has been organised in a manner that 
enables even closer co-operation among 
specialists in the ﬁelds of epidemiology, 
microbiology, data management, and 
other applicable ﬁelds.
The European Centre for Disease 
Prevention and Control (ECDC) 
integrated all data collection under one 
data system (TESSy) it administers; 
the ECDC utilises this system to 
publish reports on different classes 
of communicable diseases. Before, 
the data were collected in separate 
disease-speciﬁc databases. The ECDC, 
established in 2005, has proved its 
usefulness in many ways in international 
situations requiring urgent response, 
and it has published scientiﬁc reviews by 
groups of experts to support prevention.
In 2008, the National Infectious 
Diseases Register (NIDR) launched 
tuberculosis outcome surveillance and a 
pilot project that will enable doctors to 
report infectious diseases electronically 
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history of the NIDR, although there were 
no major campylobacter outbreaks. By 
the time of completion of this report, the 
salmonella contamination of the feed in 
poultry production facilities that was 
noticed at the beginning of 2009 was not 
evident in the number of human cases 
caused by the same salmonella serotypes 
in 2008. The number of norovirus cases 
has increased to a higher level than 
a few years ago; this is most likely due 
to implementation of microbiological 
diagnostics for norovirus in more 
general use than just during epidemics 
and institutional outbreaks. In addition 
to children, adults fell ill with hand, foot, 
and mouth disease with exceptional 
symptoms during the severe hand, foot, 
and mouth disease outbreak in the 
autumn of 2008.
Food- and water-borne outbreaks 
included the ﬁrst extensive Cryptosporid-
ium parvum outbreak in Finland and a 
normal Yersinia pseudotuberculosis out-
break in which the infection spread 
through carrots. The investigation of the 
water epidemic in Nokia in November 
2007 continued in 2008 in an exception-
ally large number of directions.
The number of hepatitis A and 
acute hepatitis B cases remained at the 
low level of the previous years. The total 
number of newly reported hepatitis C 
cases is decreasing, but, unlike in the rest 
of Finland, the incidence has increased 
in Northern Finland, especially in the 
last few years. 
The situation with sexually 
transmitted diseases remained the same 
apart from HIV infection, where the 
number of cases decreased signiﬁcantly 
after two high-incidence years. The 
continuous high number of chlamydia 
cases, totalling almost 14,000, and that 
the majority of the HIV cases are related 
to heterosexual contact prove that there 
is a need to promote more effective 
prevention of sexually transmitted 
diseases.
The antimicrobial resistance 
situation is getting worse. There were 
clearly more new MRSA cases reported 
in 2008 than in the two preceding years, 
and the numbers for MRSA detection 
from blood are also slowly increasing. 
There were almost 2,000 cases of the 
new third-generation Escherichia 
coli and Klebsiella pneumoniae ESBL 
ﬁndings with reduced susceptibility 
to cephalosporin or with resistance to 
cephalosporin.
In different countries, there were 
reports of especially severe cases of 
Clostridium difﬁcile, subtype 027, in 
particular, which causes diarrhoea 
related to antimicrobial treatment. C. 
difﬁcile ﬁndings became reportable after 
a 10-year break at the beginning of 2008, 
and strains isolated from severe cases 
were typed. C. difﬁcile was the second 
most common microbe by number 
reported to the NIDR, and typing 
indicated that, geographically, PCR 
ribotype 027 is widespread in Finland.
The drop in the number of 
tuberculosis cases stopped in 2007–
2008. The reason for the slight increase 
in the total number of cases is the 
change in the criteria for notiﬁcation 
of cases in accordance with the new 
case deﬁnitions of the European Union. 
However, there is no worsening visible 
in cases conﬁrmed by culture where the 
criteria have not changed. There have 
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been no signs of increased tuberculosis 
among children since the vaccination 
programme was changed in 2006 to 
administer a BCG vaccination only to 
risk groups. However, the outbreak in 
Pirkkala highlights the importance of 
preventing tuberculosis and of early 
diagnosis. 
Reporting showed a record number 
of Puumala virus cases causing epidemic 
nephropathy. The region where the TBE 
virus causing tick-borne encephalitis 
is endemic is spreading slowly after 
the place of acquisition has been 
systematically investigated; in 2008, 
there were individual occurrences in 
Simo and Varkaus.
There were more malaria cases 
than usual; the main reason for this was 
failure to use malaria prophylaxis, or its 
irregular use, in visitors to Gambia.
The number of severe systemic 
infections detected in blood cultures 
has increased every year and reached 
the 10,000-case threshold in 2008. 
As regards prevention opportunities, 
pneumococcus, which caused a record 
number of 900 cases conﬁrmed by 
blood culture, is especially current. A 
national expert group has proposed that 
Finland should include a pneumococcal 
conjugate vaccine in the national 
vaccination programme as one of the 
last countries in the European Union 
to do so. International studies indicate 
that vaccination of children has led 
to signiﬁcant herd immunity, which 
means that the number of cases has also 
dropped clearly in older age groups. 
Helsinki, 14 April 2009
Petri Ruutu
Research Professor
Department of Infectious Disease 
Surveillance and Control
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Respiratory infections
the basis of this antigenic variation, the 
WHO recommended bringing a new 
variant, A/Solomon Islands/3/2006, into 
use as a vaccine virus at the beginning of 
2007. This virus caused the inﬂuenza A 
outbreak in winter 2007–2008.
In autumn 2007, a free inﬂuenza 
vaccination was offered to children 
under three years of age for the ﬁrst time. 
When the virus causing the outbreak is 
very closely related to the vaccine virus, 
we can assume that the recommended 
regimen of two doses of vaccination 
before the start of the outbreak provides 
good immunity.
In October–November 2007, only 
individual occurrences of inﬂuenza A 
were reported; in December, the number 
of reported cases increased slightly. 
Inﬂuenza A
After a seven-year break, inﬂuenza A 
subtypes (H1N1) were responsible 
for the outbreak of inﬂuenza A in the 
2007–2008 epidemic season. In 2000, 
a new epidemic variant, the A/New 
Caledonia/20/99 virus, was chosen as 
the H1N1 vaccine virus. This virus 
caused an extensive outbreak in Finland 
in winter 2000–2001, especially among 
children and young adults. The same 
virus was kept in the vaccine virus for 
the next six years. Viruses such as A/
New Caledonia/20/99 caused only 
isolated occurrences or small outbreaks 
yearly both in Finland and elsewhere 
in the world. An antigenic variation in 
the H1N1 virus occurred in 2006; on 
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Figure 1. Inﬂuenza A cases by month, 1995–2008.
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The actual epidemic peaked in 
January–February 2008. In garrisons, 
the epidemic started right after new 
conscripts arrived in the second week 
of January. Of all cases of inﬂuenza A 
diagnosed in January, about one case 
in three was diagnosed in the group of 
15–24-year-olds, of whom the majority 
were conscripts. After this, the epidemic 
also spread to general population. In 
February, more than a third of the 
inﬂuenza A cases were diagnosed in 
children under 10 years of age. Inﬂuenza 
A (H1N1) viruses are usually considered 
viruses that affect children and young 
adults. This was once again evident 
in 2007–2008, when 31% of the cases 
reported to the NIDR were diagnosed 
in children under age 10 and 18% in the 
10–19 age group. Almost 45% of all cases 
were diagnosed in 20–49-year-olds, with 
only a scant two per cent in people over 
59 years of age. In 2007–2008, subtype 
H3N2 of the inﬂuenza A virus caused 
only isolated occurrences in Finland. 
In January 2008, inﬂuenza A 
(H1N1) viruses with resistance to 
oseltamivir (Tamiﬂu®) were observed in 
Europe; however, the medicine had not 
been used more than in previous years. 
Resistant viruses were able to spread 
from one person to another and to cause 
common symptoms of inﬂuenza. The 
resistant viruses were detected both in 
Finland and elsewhere in the world. We 
are monitoring the situation closely. 
Inﬂuenza B
In winter 2007–2008, the number of 
inﬂuenza B cases reported to the NIDR 
totalled 1,807, which is nearly equal 
to the number of inﬂuenza A cases. 
There are two lineages of inﬂuenza 
B virus, Yamagata and Victoria. The 
autumn 2007 vaccine included the B/
Malaysia/2506/2004 virus, which was 
already in the vaccine of the previous 
year. This virus represents the Victoria 
lineage. However, the inﬂuenza B 
outbreak in winter 2007–2008 was 
caused by the Yamagata lineage, which 
means that the protection given by the 
vaccine was relatively weak. Only 43 
cases of inﬂuenza B were diagnosed 
toward the end of 2007. The epidemic 
developed during January 2008, and 
in February–March there were several 
cases of inﬂuenza B. Then, 332 inﬂuenza 
B cases were reported to the NIDR 
in April. Children under 10 years of 
age accounted for almost 25% of all 
inﬂuenza B cases, with the same number 
of cases diagnosed among 30–39-year-
olds. Is it possible that the virus has 
spread from children to their parents? 
In the 15–24 age group, which includes 
conscripts, diagnosed inﬂuenza B cases 
accounted for only a little over ﬁve per 
cent of all cases, as many as in over-
59-year-olds. There were still cases of 
inﬂuenza B in May, when 50 cases were 
diagnosed.
Respiratory syncytial virus 
(RSV)
In 2008, 1,900 cases of RSV conﬁrmed 
with laboratory tests were reported to 
the NIDR (incidence: 36/100,000). This 
is a three-year record. The previous 
peak, with 2,330 cases, was observed in 
2005. In Finland, RSV follows a regular 
two-year pattern; in uneven years, there 
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is a minor epidemic in the spring, with 
a more violent attack in the following 
winter. In 2008, there was a winter 
epidemic that peaked in February. The 
incidence of RSV varied by hospital 
district (4–52/100,000), most likely 
caused by differences in the use of 
laboratory diagnostics. As before, nine 
out of 10 RSV cases were diagnosed in 
0–4-year-olds. Even though infections 
occur in all age groups, babies and small 
children constitute the majority of cases 
leading to hospitalisation and laboratory 
diagnostics.
Legionella
In 2008, twenty-eight cases of Legionella 
were reported to the register on the 
basis of laboratory ﬁndings. In six cases, 
the diagnosis was based on detection 
of antigen in the urine, in two cases 
on sputum or bronchoalveolar lavage 
ﬂuid culture or PCR, and the rest 
on serological methods. In further 
investigations, the clinical picture was 
found to be consistent with legionellosis 
in 17 cases; in other words, the patient 
had symptom-based or radiologically 
diagnosed pneumonia. All six patients 
whose Legionella was conﬁrmed by a 
urinary antigen test had pneumonia, 
as did the patients whose Legionella 
was detected in a sputum or BAL ﬂuid 
culture. Of the patients, 16 were men and 
12 were women. Their ages ranged from 
20 to 82 years. In 2008, a 57-year-old 
woman died of legionellosis. She suffered 
from multiple diseases and had visited 
Turkey before falling ill. As before, about 
half of the legionellosis patients had been 
abroad prior to falling ill. Twelve of them 
had lived in a hotel while abroad. The 
accommodation data of these patients 
were reported to EWGLINET (European 
Surveillance Scheme for Travel Associated 
Legionnaires’ Disease), which collects 
data on travel-associated Legionella.
	  
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Figure 2. RSV by month, 1995–2008. 
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Whooping cough 
(Bordetella pertussis)
In 2008, the number of whooping cough 
cases reported to the NIDR totalled 511 
(10/100,000). The number of cases has 
remained stable for the past few years 
and has clearly decreased since the record 
year 2003–2004. The majority of cases 
were diagnosed from antibody testing. 
Twenty-nine of the patients were under 
12 months old, with 19 under three 
months old. As in the previous year, the 
majority of patients (131) were 15–19 
years of age. Before, the majority of cases 
were diagnosed in younger children 
and schoolchildren. In 2008, about half 
of the cases were diagnosed in over-20-
year-olds. That whooping cough has 
been diagnosed in older age groups 
in increasing amounts is most likely a 
consequence of the booster vaccinations 
that have been administered to six-year-
olds since 2003 and to four- and 14-year-
olds since 2005. Once again, incidence 
of whooping cough varied by hospital 
district (2–39/100,000). Incidence rates 
were highest in the hospital district of 
Keski-Pohjanmaa and lowest in the 
hospital district of Itä-Savo.
	  
     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Figure 3. Whooping cough by month, 1995–2008.
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Gastrointestinal infections
380 (14%), similar to the ﬁgure for 
2007, with an incidence of 7/100,000 
population. Forty-eight different 
serotypes caused domestic salmonella 
infections. The leading ﬁve serotypes 
were Typhimurium (22%), Newport 
(19%), Enteritidis (13%), Reading (7%), 
and Mikawasima (6%). The S. Newport, 
Reading, and Mikawasima cases were 
mainly connected to the outbreaks 
caused by these serotypes. Endemic 
phage type FT1 caused the majority of 
the domestic S. Typhimurium cases. 
Sixty-nine per cent of the cases were 
susceptible to antimicrobials with an 
STYMXB.0098 DNA proﬁle.
The total number of foreign 
salmonella infections was 2,605, and the 
incidence was 49/100,000 population. 
The salmonella infections acquired 
abroad represented in excess of 100 
serotypes. The S. Enteritidis serotype 
caused 1,066 (41%) of the cases with 
foreign origin. The next most common 
serotypes acquired abroad were 
Typhimurium (198 cases), Stanley (136), 
Virchow (115), and Newport (76). The 
leading countries of acquisition were 
Thailand (35%), Greece (9%), Egypt 
(5%), and Turkey (5%).
There were 935 strains phage-typed 
from the foreign Enteritidis strains and 
170 from the Typhimurium strain. The 
prevailing phage types among Enteritidis 
were FT 21 (20%), FT 14b (14%), and 
FT 1 (13%) and among Typhimurium 
were FT NST (24%), FT 195 (18%), and 
FT 120 (14%).
Salmonella
The year saw a total of 3,142 cases of 
salmonella reported to the register, 
compared with 2,753 cases in the 
year before. In 2007 and 2008, there 
were more reported cases than in the 
preceding years. Fifty-four per cent 
of the patients were women. Annual 
incidence in the entire country was 
59/100,000 population. Incidence 
was highest in the hospital districts of 
Itä-Savo (79/100,000) and Satakunta 
(75/100,000) and lowest in the hospital 
districts of Kainuu (31/100,000) and 
Länsi-Pohja (33/100,000). Incidence was 
highest (83–89/100,000) in 20–49-year-
olds and lowest (10/100,000) in over-70-
year-olds.
The most common Salmonella 
serotypes were Enteritidis (983 cases), 
Typhimurium (255 cases), Stanley 
(132 cases), and Virchow (110 cases). 
More than one salmonella serotype was 
detected in 43 patients.
There were two diagnosed cases 
of the Typhi serotype, which causes 
typhoid; six cases of S. Paratyphi A, 
which causes paratyphoid; and ﬁve cases 
of S. Paratyphi B. All cases of S. Typhi and 
S. Paratyphi A were contracted abroad. 
S. Paratyphi A infections were most 
commonly acquired in India. Three out 
of ﬁve patients with S. Paratyphi B had 
been abroad: in Turkey, in Bangladesh, 
and in Iraq.
The total number of domestically 
acquired salmonella infections was 
12
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According to ‘epidemiological’ 
susceptibility testing involving 12 
antimicrobials, seven per cent of Finnish 
and 14% of foreign salmonellas were 
multiresistant (i.e., resistant to at least 
four antimicrobials). Nalidixic acid is 
used in epidemiological susceptibility 
testing, and data on lowered susceptibility 
(R or I) to nalidixic acid can be used to 
predict reduced susceptibility (MIC  
0.125 mg/L) to ﬂuoroquinolones. Eight 
per cent of domestic strains and 28% of 
foreign strains showed disk susceptibility 
R or I to nalidixic acid. Of these, 90% 
showed reduced susceptibility to 
ciproﬂoxacin and two per cent were 
completely resistant (MIC  4.0 mg/L).
Campylobacter
In 2008, the NIDR received 4,453 
notiﬁcations of campylobacter infections. 
This is eight per cent (346 cases) higher 
than in 2007. Campylobacter jejuni was 
clearly the prevailing campylobacter 
species (3,468 cases). There were 
202 reported cases of C. coli and 780 
untyped campylobacter ﬁndings. The 
incidence rate in the entire population 
was 85/100,000. Fifty-two per cent of 
the patients were men. The highest 
incidence was among 30–34-year-olds 
(173/100,000). Incidence was highest 
in the hospital district of Helsinki and 
Uusimaa (135/100,000). The seasonal 
variation was typical for campylobacter: 
incidence was highest in July–August.
In 3,223 cases (72%), information 
was obtained about recent travels 
abroad. Of the patients concerned, 77% 
had been abroad just before falling ill. 
The leading countries of acquisition 
were Thailand (431 cases), India (217 
cases), Spain (210), and Turkey (195).
	  
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Figure 4. Salmonella and campylobacter cases by month, 1995–2008.
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Table 1. The most common serotypes of salmonella cases, 1997–2008.  
(S. Typhi and S. Paratyphi not included).
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Infections acquired abroad
Salmonella Enteritidis 912 944 892 1046 1238 904 907 774 834 879 735 1066
Salmonella Typhimurium 159 133 103 204 139 115 135 166 194 141 246 198
Salmonella Virchow 85 82 76 49 79 55 67 74 88 80 135 115
Salmonella Hadar 57 79 112 125 96 69 58
Salmonella Newport 34 53 66 76
Salmonella Infantis 67
Salmonella Braenderup 38 49
Salmonella Stanley 62 65 67 105 113 116 175 136
Salmonella Corvallis 60 59
Other 758 827 680 747 757 636 628 665 654 745 920 1014
Total 2005 2132 1901 2220 2371 1844 1862 1837 1943 2027 2270 2605
Domestically acquired infections
Salmonella Typhimurium 499 222 375 124 152 222 137 131 240 170 150 80
Salmonella Enteritidis 79 59 83 52 63 42 61 81 75 69 61 49
Salmonella Hvittingfoss 26
Salmonella Hadar 31 10 17
Salmonella Infantis 24 21 19 10
Salmonella Newport 22 66 16 7 9 23 70
Salmonella Saintpaul 22
Salmonella Agona 85 27 41 16 12 27 32 40
Salmonella Poona 10 9
Salmonella Virchow 15 11
Salmonella Ohio 12
Salmonella Abony 15
Salmonella Stanley 8 5 12
Salmonella Give 39
Salmonella Reading 25
Salmonella Mikawasima 23
Other 153 122 93 90 103 85 75 81 80 98 86 127
Total 808 512 656 325 390 406 310 335 442 396  372 374
Country of acquisition not speciﬁed
Number of cases 233 301 476 223 145 102 107 86 111 153 93 150
Total 3046 2945 3033 2768 2906 2352 2279 2258 2496 2576 2735 3129
14
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Yersinia
Yersinia enterocolitica 
In 2008, the NIDR received 466 
notiﬁcations of Yersinia enterocolitica, 
which is a 13% increase from the 
ﬁgures for 2007 (414 cases). In 2008, 
the incidence in the entire country 
was 9/100,000 population. The highest 
incidence rate was reported among 
over-75-year-olds (15/100,000). There 
is great regional variation in the number 
of Yersinia enterocolitica cases, with 
the highest incidence reported in the 
hospital district of Kainuu (27/100,000 
population). 
Yersinia pseudotuberculosis 
The number of Yersinia 
pseudotuberculosis cases (132 cases) 
rose after the low ﬁgure (56) seen in 
2007. No distinct trend can be seen in 
the incidence of Y. pseudotuberculosis 
cases; in many years, outbreaks have 
caused great variation in the number of 
cases. In 2008, the incidence in the entire 
country was 2.5/100,000 population. 
The number of cases is too low to 
reliably indicate any regional variation. 
The outbreak in Kainuu can be seen in 
the high incidence rate for that hospital 
district, while no cases were diagnosed 
in nine of the hospital districts in 2008. 
Shigella
In 2008, the incidence of shigellosis 
was 2.4/100,000. There were 124 
reported cases, 52 in men and 72 in 
women. Incidence was highest among 
25–49-year-olds (6.9). More than half 
of the cases (66) were diagnosed in the 
Helsinki and Uusimaa hospital district, 
where incidence was also higher than in 
Figure 5. Yersinia enterocolitica cases 1995–2008.
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the other hospital districts (4.6/100,000). 
Six hospital districts had no diagnosed 
cases. Of the total, 113 infections were 
acquired abroad and three in Finland. 
In eight cases, the country of acquisition 
was not speciﬁed. The prevailing shigella 
species were Shigella sonnei (88 cases) 
and S. ﬂexneri (23 cases). There were 
only four cases of S. dysenteriae. The 
leading countries of acquisition were 
India (25) and Egypt (21). Seventy-
two per cent of the shigella strains were 
resistant to at least four antimicrobials, 
with 28% resistant to nalidixic acid and 
about 94% of these exhibiting impaired 
susceptibility to ciproﬂoxacin (MIC at 
least 0.125 mg/L). The nalixidic-acid-
resistant strains were mainly acquired in 
India, as were the strains most resistant 
to ciproﬂoxacin (MIC at least 4 mg/L). 
Three shigella strains showed reduced 
susceptibility (I) to cefotaxime in disk 
susceptibility testing; these strains, which 
represented S. sonnei, were acquired in 
Turkey.
Enterohaemorrhagic 
Escherichia coli (EHEC)
Eight microbiologically conﬁrmed cases 
of enterohaemorrhagic Escherichia coli 
were reported to the NIDR (0.2/100,000/
year). A few cases are diagnosed each 
year, most of which have been acquired 
abroad. In 2008, three cases were 
diagnosed in women and ﬁve in men. 
Five of the patients were under 15 years 
old, three of them 0–4-year-olds. None of 
the patients are known to have suffered 
from haemolytic-uremic syndrome as a 
complication. In four cases, the infection 
was acquired abroad.
Three of the cases were caused by 
the O157 serogroup strains, all of them 
Figure 6. Yersinia pseudotuberculosis cases 1995–2008.
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of foreign origin. Non-O157-serogroup 
strains caused four infections, three of 
them in one family. 
Norovirus
In 2008, there were 2,574 reported cases 
of norovirus, 1,527 of them (59%) in 
women. The incidence rate, 49/100,000, 
was nearly as high as that for 2007. Over 
80% of the cases were reported between 
January and May. More than half (55%) 
of the patients were over 75 years of age, 
with an incidence rate of 362/100,000, 
but infections were diagnosed in all 
age groups. The highest incidence rates 
were reported in the hospital districts 
of Keski-Pohjanmaa, Länsi-Pohja, and 
Kainuu.
The accumulation of norovirus 
cases in the ﬁrst part of the year was the 
result of a high number of outbreaks in 
institutional settings. This also explains 
the high incidence among the elderly and 
the considerable regional variation. The 
main cause of these outbreaks was the 
GII.4 norovirus variant (GII4-2006b), 
which emerged in 2006. The other new 
norovirus variant, GII4-2006a, which 
also emerged in 2006, disappeared 
completely in 2008. In addition to the 
dominant variant GII4-2006b, some 
infections caused by the genotypes GII.7 
and GI.3B were diagnosed throughout 
the year. 
Rotavirus
In 2008, there were 1,337 reported 
rotavirus cases, with an incidence of 
25/100,000. Of these cases, 740 were 
diagnosed in men and 597 in women. 
The number of cases was clearly higher 
than in 2007, when the number of cases 
Figure 7. Norovirus cases by month, 2005–2008.
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saw a record low. The monthly variation 
of incidence rates followed the normal 
pattern: the number of cases increased 
over the spring, peaking in April, and 
decreased in June–July. The incidence 
was clearly highest in children under 
ﬁve years of age (424/100,000). They 
constituted 90% of all cases. Cases were 
reported from all hospital districts, 
with the highest incidence seen in the 
hospital district of Kainuu (75/100,000). 
These are interesting times with regard 
to rotavirus, as the ﬁrst rotavirus vaccine 
was launched in Finland in the summer 
of 2006. At ﬁrst, the vaccine was used 
sporadically, but its use increased 
vigorously in 2007. A decision has been 
made to add the children’s rotavirus 
vaccine to the national vaccination 
programme. As of September 2009, the 
vaccine will be available free of charge 
from healthy baby clinics to children six 
weeks of age or older.
Enterovirus
In 2008, there were 352 reported cases 
of enterovirus. Of the patients, 209 
were men and 143 women. More than 
half (58%) of the patients were under 
nine years of age, but infections were 
diagnosed in all age groups.
Most of the year’s enterovirus 
diagnoses were made in the last quarter 
of 2008. Roughly 88% of the cases 
occurred in September–October, when 
an unusually extensive hand, foot, 
and mouth epidemic broke out in 
Finland. During the outbreak, several 
adults were also infected with the 
disease, exhibiting strong symptoms. 
The hand, foot, and mouth disease 
outbreaks were caused by two poorly 
known coxsackie viruses, CAV-6 and 
CAV-10. There was an exceptional 
symptom associated with the epidemic: 
several patients lost nails.
Listeria
Thirty-nine Listeria monocytogenes 
infections were reported in 2008. Of 
these patients, 54% were women and 
74% were 65 years of age or older. The 
annual incidence of listeriosis was 7.4 
cases per million population. There were 
33 blood ﬁndings (77%) and three CSF 
ﬁndings. One ﬁnding was obtained from 
both blood and CSF, and two from other 
puncture samples. Three patients died. 
None of the cases were associated with 
pregnancy, and only one of the patients 
was a child. Listeriosis was diagnosed in 
most hospital districts, with the number 
of cases ranging from zero to 13; in six 
of the hospital districts, no cases were 
diagnosed. Serotype 1/2a accounted for 
60% of the infections, and serotype 4b 
for 33%.
In 2008, two infection clusters were 
detected that were caused by genetically 
similar Listeria monocytogenes types. 
One of these included ﬁve cases and the 
other one eight. The source of infection 
of the ﬁrst cluster remained unclear, and 
the epidemiological investigation of the 
second cluster is still in progress at the 
time of writing.
Food- and water-borne 
outbreaks
In 2008, the National Public Health 
Institute received 80 notiﬁcations 
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of suspected food- or water-borne 
outbreaks. These included a Yersinia 
pseudotuberculosis outbreak in 
Kainuu, where the infection spread 
through carrots, as well as an extensive 
Cryptosporidium parvum outbreak 
in Helsinki diagnosed in Finland for 
the ﬁrst time. Several other intestinal 
infection clusters were investigated as 
well.
Cryptosporidium parvum 
outbreak in Helsinki
Seventy-two people who had eaten at 
the staff cantine of the Helsinki Public 
Works Department fell ill between 30 
October and 14 November 2008 with 
diarrhoea caused by Cryptosporidium 
parvum. In addition to diarrhoea, 
patients suffered from severe 
abdominal pain and nausea. The source 
of infection was investigated through a 
questionnaire and extensive tracing. 
Lettuce of foreign origin was suspected 
as the source of infection, but no 
conﬁrmation was received during the 
investigation.
Campylobacter outbreak in 
Korpilahti
At the end of July, tens of people fell 
ill with gastroenteritis in Korpilahti 
as a result of Campylobacter jejuni. In 
further investigation, small numbers 
of indicator bacteria were found in the 
samples taken from the water intake, 
but no campylobacter was found. Apart 
from water for household consumption, 
there were no other common factors 
among the patients, so drinking water 
was considered the likely source of 
infection.
Salmonella Mikawasima 
outbreaks in February and in 
November
Nine Salmonella Mikawasima infections 
were diagnosed in Southern and 
Western Finland in February. All 
strains represented genotype SMIK5. 
Mikawasima is a rare serotype in 
Finland. However, small clusters caused 
by it are diagnosed almost yearly, as seen 
in, for example, 2006 and 2007. The 
second Salmonella Mikawasima cluster 
of 2008 was observed in November, 
when an infection caused by the SMIK3 
genotype was diagnosed in 15 patients. 
These patients were cruise ship staff, and 
only two of them displayed symptoms 
of contracting salmonella. The other 
cases were diagnosed when the 
personnel underwent extensive testing 
for salmonella. The source of infection 
could not be identiﬁed in further 
investigation. No cases were diagnosed 
among the passengers.
Salmonella Poona outbreak 
From the end of April to the end of 
June, 16 cases of Salmonella Poona 
were diagnosed, all over Finland. The 
strains represented four different DNA 
proﬁles, although the majority (10 
strains) was identical in DNA proﬁle. 
Some of the strains were separated by 
a 4–9 DNA fragment. Therefore, some 
strains should not have been considered 
part of the same outbreak, according 
to internationally accepted practice. 
However, since S. Poona is a rare serotype 
in Finland (e.g., in 2007, no domestic 
cases were diagnosed) and all Poona 
ﬁndings in 2008 (apart from one case in 
October) were made in a short period of 
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time, the infections were judged to have 
had a common source. Poona is a rare 
serotype in other European countries as 
well. Individual S. Poona cases occurred 
more than usual in some other European 
countries also between April and June. 
In Scotland, ﬁve cases were diagnosed 
that had an identical genotype to the 
S. Poona seen in Finland. The Finnish 
patients were interviewed, but no 
common predisposing factor was found.
Salmonella Newport and 
Salmonella Reading outbreaks
From mid-October to the end of 
November, more than 70 cases of 
Salmonella Newport and almost 30 
cases of Salmonella Reading were 
diagnosed, all over Finland. Both 
serotypes are rare in Finland. No 
increase in the number of cases was 
detected elsewhere in Europe. Some of 
the infections occurred in clusters in 
Helsinki, Tuusniemi, Rovaniemi, and 
Kymenlaakso. In all cases, the common 
factor was institutional eating. The 
source of infection was investigated 
by interviewing the patients and the 
treatment personnel, by tracing food 
delivered to the institutional kitchens, 
and via a case-control study, but the 
source has not been detected so far.
Salmonella Anatum outbreak 
Seven cases of Salmonella Anatum were 
diagnosed in the Joensuu region from 
mid-August to the end of October. 
The strain, representing genotype 
SANT9, was susceptible to tested 
antimicrobials. The same Anatum 
type has been diagnosed in patients in 
Finland periodically since 2006. The 
DNA proﬁles of the strains isolated from 
humans are different from the DNA 
proﬁles of Anatum strains isolated from 
animals and food by the Finnish Food 
Safety Authority (Evira).
Salmonella Enteritidis outbreak in 
a spa in Estonia
In August, Salmonella Enteritidis FT 14b, 
genotype SENT1 caused an epidemic 
in a spa in Estonia. There were 25 
microbiologically conﬁrmed salmonella 
infections diagnosed in Finns visiting 
the spa.
Yersinia pseudotuberculosis 
outbreak in Kajaani and Oulu
From the end of June, more than 
30 cases of gastroenteritis caused by 
Yersinia pseudotuberculosis bacteria 
were diagnosed in the hospital district 
of Kainuu. Symptoms included severe 
abdominal pain, fever, and diarrhoea. 
Most patients started suffering from 
these symptoms in June–July. Some of 
the patients suffered from complications, 
such as erythema nodosum or reactive 
arthritis. There were 38 culture-
conﬁrmed cases diagnosed in Kajaani 
and 11 in Oulu between 22 June and 
11 August 2008. The majority of the 
diagnoses were in working-age men. It 
is suspected that the epidemic broke out 
from contaminated carrots that were 
served in several institutional kitchens 
in the Kajaani and Oulu regions. Y. 
pseudotuberculosis O:1 bacteria with 
identical genotype were found in both 
patient and carrot samples.
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Hepatitis
adverse effect prevention work targeted at 
injecting drug users, still are keeping the 
number of cases low (Figure 8, Table 2). 
As in the previous year, only one case of 
acute hepatitis B associated with injecting 
drug use was diagnosed in 2008.
Hepatitis C 
The slow drop in the number of newly 
diagnosed hepatitis C cases has been 
the trend of the past decade. This trend 
continued in 2007, although there was 
some regional variation. It is difﬁcult 
to separate acute hepatitis C infections 
from infections acquired years earlier, 
which is why any changes in the ﬁgures 
should be interpreted cautiously. The 
frequency of hepatitis C is so high 
among injecting drug users that changes 
in frequency are very slow, even if the 
risks were well under control.
According to reports, most hepatitis 
C cases are related to injecting drugs 
(Table 3). The number of these cases has 
decreased in the 2000s (928 cases in 2000 
and 508 in 2008). The number of HCV 
and HBV cases wherein the mode of 
transmission remains unknown is large 
(513 cases in 2008). In general, these 
HCV cases are considered to be related 
to injecting drug use because HCV is 
not transmitted easily through sexual 
contact and no community transmission 
has been detected. However, the yearly 
number of unclear cases is surprisingly 
high and the underlying hidden risk 
factors should be investigated further.
Hepatitis A
In 2008, the NIDR received 21 
notiﬁcations of hepatitis A (incidence: 
0,4/100,000), which is the same ﬁgure 
as in the previous years. Ten patients 
were men, and 11 were women. Most 
cases (9) were diagnosed in the hospital 
district of Helsinki and Uusimaa, while 
12 hospital districts had no diagnosed 
cases. Twelve infections were acquired 
abroad and three in Finland. In eight 
cases, the country of acquisition was not 
speciﬁed. 
The incidence of hepatitis A has 
remained low following the epidemics 
among injecting drug users in 2002–
2003, possibly because of vaccinations 
targeted at risk groups and tourists. 
The family of a hepatitis A patient must 
always be protected by gamma globulin 
or via vaccination.
Hepatitis B
In 2008, there were 46 cases of recent 
hepatitis B (acute hepatitis B infection) 
reported, which is a little higher than 
the previous year’s ﬁgure, but this is still 
considerably lower than the level of the 
peak years in the 1990s. There is little 
variation in incidence rates between 
hospital districts.
Thirty-three patients were men, and 
13 were women. It seems that including 
hepatitis B vaccinations in the general 
vaccination programme for risk groups, 
as well as the health counselling and 
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1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Injecting drugs 76 107 82 28 43 18 8 3 4 1 1
Sex 45 36 39 41 37 19 16 10 15 7 13
Perinatal 1 1 1 - 1 1 - - - - -
Blood products 4 1 1 1 1 - 3 - - - -
Other 4 9 8 6 2 1 4 3 2 1 2
Unknown 116 103 109 51 93 67 28 18 16 14 29
Total 246 258 240 127 177 106 59 34 37 23 45
Table 2. Acute Hepatitis B cases by mode of transmission from physician notiﬁcations, 1998–2008 *)
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Injecting drugs 1047 1001 928 822 710 627 603 621 571 416 508
Sex 55 35 41 42 45 46 59 61 70 63 68
Perinatal 4 10 6 3 3 1 10 5 8 4 9
Blood products 27 23 25 19 18 22 18 24 7 17 15
Other 24 40 31 31 28 34 31 35 37 23 31
Unknown 646 643 708 574 567 533 517 497 486 634 513
Total 1803 1753 1739 1492 1372 1264 1238 1244 1181 1157 1144
Table 3. Hepatitis C cases by mode of transmission from physician notiﬁcations, 1998–2008 *)
Figure 8. Acute Hepatitis B cases injecting drugs and sexually transmitted infections, 1998–2008.
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*) Between 1995–2003 four HBV-cases have been notiﬁed to have been transmitted by Finnish 
blood products. Since 2000 no cases of HCV transmitted by Finnish blood products have been 
notiﬁed. The surveillance for the mechanism of transmission for HCV was started in 1998.
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With regard to age groups, 
the number of HCV cases among 
15–19-year-olds has fallen to less than 
half since 2002 (Figure 9). There are 
signs of a decline among 20–24-year-olds 
as well. In older age groups, the number 
of cases has fallen less dramatically. This 
may suggest that the health counselling 
and harm reduction targeted at injecting 
drug users have been so successful in 
infection risk prevention that an HCV 
infection is acquired later in life than 
before if the drug use continues for 
a long time. It seems that the health 
counselling provided for injecting drug 
users and the harm reduction has had its 
best results in the youngest age groups, 
which was one of the main goals.
As regards regional patterns, the 
incidence of HCV has decreased in 
the provinces of Western, Eastern, 
and Southern Finland. The situation 
is starting to cause concern in the 
province of Oulu, where the incidence 
rate has increased almost non-stop 
since 1995. In 2008, there were 129 new 
HCV cases diagnosed in the Pohjois-
Pirkanmaa hospital district (Figure 10), 
and the reasons for this growth should 
be investigated. The growth could be 
explained in part by testing that is more 
active than in the rest of Finland, but 
the increase in the number of cases in 
the past few years in particular has been 
quite clear.
Because of the high incidence in 
Northern Finland, situations where 
injecting drug users use drugs in the 
region should be investigated and, 
if necessary, health counselling for 
injecting drug users should be increased 
to curb the infection rates. 
Figure 9. Hepatitis C cases by age, 1998–2008.
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Figure 10. Incidence of Hepatitis C in Finland 2008 by hospital district.
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Sexually transmitted diseases
Gonorrhoea 
(Neisseria gonorrhoeae) 
The number of gonorrhoea cases 
remained nearly the same as in the 
previous year. The NIDR received 
202 notiﬁcations of gonorrhoea. The 
incidence rate was 3.8/100,000. Seventy-
nine per cent of the patients affected 
were men. The majority of cases (76%) 
were diagnosed among 20–49-year-olds. 
The country of acquisition was speciﬁed 
in 76% of the cases. More than 53% of 
the infections in men were contracted 
abroad. In 33 cases, the infection was 
acquired in the Far East (26%). Six 
cases in women were contracted abroad 
(14%). 
Chlamydia 
(Chlamydia trachomatis)
In 2008, the number of chlamydia cases 
reported to the NIDR totalled 13,871, 
which is nearly equal to the ﬁgure for 
2007 (13,973). The incidence rate was 
266/100,000. The highest incidence of 
chlamydia cases was detected in the 
hospital districts of Lappi (441/100,000), 
Helsinki and Uusimaa (302/100,000), and 
Pirkanmaa (296/100,000). About 59% of 
the patients were women. The majority of 
the cases were diagnosed in 15–24-year-
old women (73%) and 20–24-year-
old men (65%). As previously, among 
under-20-year-olds, women constituted 
a signiﬁcantly larger group of patients 
(2,779) than men did (797).
Figure 11. Chlamydia by age groups in young adults, 1995–2008.
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Syphilis 
(Treponema pallidum)
There were 215 syphilis cases reported 
in 2008. The ﬁgure was slightly higher 
than in 2007 (184). The incidence rate 
was 4.1/100,000. Sixty-four per cent 
of the cases were diagnosed in men. 
Sixty-one per cent of all cases were 
diagnosed in 25–49-year-olds. The 
incidence was greatest in the hospital 
districts of Etelä-Karjala (10.1/100,000), 
Helsinki and Uusimaa (8.7/100,000), 
and Kymenlaakso (5.0/100,000). As 
in the previous year, several cases of 
syphilis were diagnosed in men in 
the hospital district of Helsinki and 
Uusimaa (incidence rate: 11.6/100,000). 
The country of acquisition was speciﬁed 
in 68% of men’s infections, and of 
these cases 46% were acquired abroad, 
most often in Russia (8). The country 
of acquisition was identiﬁed in 51% of 
women’s infections. Seven women had 
acquired the infection in Finland and 32 
abroad, most often in Russia.
HIV infection
In 2008, the number of newly diagnosed 
HIV cases decreased when compared 
with the two previous years’. There 
were 148 newly diagnosed cases, 86 
of them in Finns. Of the infections, 
103 were sexually transmitted, 72 of 
them in men. The biggest decrease 
was detected for cases related to sexual 
transmission between men, although 
Table 4. Gonorrhea infections acquired domestically and abroad, 1995–2008.
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Domestically 
acquired 
infections
185 83 94 100 108 129 113 100 89 133 133 112 79 80
Russia 70 50 42 49 42 48 34 28 9 7 23 12 6 16
Estonia 26 9 7 9 8 7 3 5 2 6 1 2
Thailand 9 9 7 16 19 18 17 31 27 38 30 42 44 34
Muu maa 25 20 19 24 16 32 26 18 21 21 20 25 21 23
Place of 
acquisition 
unknown
63 55 49 71 62 50 54 53 41 47 33 45 42 49
Total 378 226 218 269 255 284 247 235 189 252 240 236 195 202
Table 5. Syphilis infection acquired domestically and abroad, 1995–2008.
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Domestically 
acquired 
infections
48 53 50 46 21 54 32 24 30 22 25 20 54 58
Russia 49 57 48 33 43 80 49 22 18 16 22 17 16 24
Estonia 5 11 5 5 3 3 2 1 6 1 6 3 4 9
Somalia 1 2 5 2 1 2 2 3 3 4 6
Thailand 1 1 4 1 1 1 2 1 1 2 6
Muu maa 9 12 14 13 14 17 11 12 14 12 16 17 21 30
Place of 
acquisition 
unknown
56 85 52 81 57 49 63 67 62 57 69 70 83 82
Total 168 219 172 187 140 204 159 128 133 110 143 131 188 215
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it is still too early to tell whether this is 
a transitory phenomenon. Evaluation 
is difﬁcult because, in Finland, there 
is no researched information available 
on the risks of sexually transmitted 
diseases related to sexual behaviour 
or getting tested for HIV. However, on 
the positive side, as regards diagnosed 
cases, Finland has moved in a different 
direction than the rest of Europe, at 
least in 2008. The number of HIV cases 
transmitted through injecting drug use 
has continued to drop, and there were 
six cases reported for this risk group, of 
which only two were diagnosed in Finns.
Although it seems that the total 
number of HIV cases has decreased 
since the peak years, the number of 
cases related to heterosexual contact 
has decreased less than that of cases 
related to homosexual contact, and, in 
2008, almost half of the cases related 
to sexual contact among Finns were 
transmitted through heterosexual 
contact. This may be a sign of still not 
realising the importance of safe sex or 
not understanding that everyone is at 
risk. The breakdown of cases by gender 
did not change from the preceding years.
Travel-related risks are still 
considerable. At least half of the infections 
contracted by Finns were probably 
acquired abroad. Subtype determination 
indicates that the proportion may be 
even greater than this. In 2008, subtype 
determination could be done in 116 cases. 
Almost half of these represented subtype 
B, which is the prevailing type in the 
homosexual contact group in particular. 
The next most common subtypes were 
CRF01-AE and CRF06-cpx, common in 
South-east Asia and Estonia.
There were no signiﬁcant changes 
in the number of AIDS cases or in AIDS 
mortality. There are not many cases, but 
there are still too many, given that deaths 
are completely preventable through 
early diagnosis
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Figure 12. Hiv cases detected among immigrants and Finns 1980–2008.
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Antimicrobial resistance
hospital district (0.7/100,000). The 
other hospital districts reported one to 
three cases each, totalling 12.
As earlier, the hospital district 
of Helsinki and Uusimaa and that of 
Pirkanmaa reported the highest total 
ﬁgures. However, the incidence per 
100,000 population was highest in 
the hospital districts of Länsi-Pohja, 
Pirkanmaa, and Pohjois-Karjala. As 
earlier, the majority of the patients were 
over 75 years of age. The number of 
children’s MRSA infections increased a 
bit (58–83), but the proportion remained 
at less than ﬁve per cent.
In 2008, an MRSA strain was typed 
in over 1,750 individuals. About 30% of 
the MRSA cases represented type FIN-
16, which has been the prevailing strain 
type in Finland for four years in a row. 
The number of FIN-16 strains grew 25% 
MRSA
In 2008, the situation with methicillin-
resistant Staphylococcus aureus (MRSA) 
worsened. More than 1,700 MRSA 
infections were reported to the Infectious 
Diseases Register (1,285–1,317 in 2006–
2007). Nearly a ﬁfth (19%, or 337/1,740) 
was diagnosed from samples taken from 
the nose or the nostrils. The proportion 
was higher than in 2006–2007 (12–14%) 
and almost as great as in 2004 (22%), 
when the MRSA situation worsened for 
the last time, reﬂecting high screening 
activity. There were 38 cases of MRSA 
isolated from the blood (in 2006–2007, 
there were 32–36 cases) and one from 
CSF. Sixteen (42%) MRSA ﬁndings 
in blood were made in the Pirkanmaa 
hospital district (3.4/100,000) and 10 
(26%) in the Helsinki and Uusimaa 
Figure 13a. MRSA cases by hospital district, 1995–2008.
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from the previous year’s level. The ma-
jority (78%) of the FIN-16 strains were 
diagnosed in Pirkanmaa, with the rest 
spread among 13 different hospital dis-
tricts. Other common strains diagnosed 
in several hospital districts included FIN-
10, FIN-4, FIN-12, and FIN-7. In com-
parison with the 2007 ﬁgure, the number 
of FIN-12 strains nearly tripled, the 
number for FIN-10 grew to be 2.5 times 
as high, and the number of FIN-4 strains 
grew by about 1.4 times. The number of 
FIN-7 strains fell. There were one or two 
prevailing strains in the hospital districts 
with the highest incidence: FIN-10 in the 
hospital district of Länsi-Pohja, FIN-16 
Table 6. MRSA-ﬁndings and their proportion of Staphylococcus aureus blood culture 
ﬁndings in 1995–2008.
Year All MRSA-ﬁndings S. aureus –ﬁndings from 
blood
MRSA-ﬁndings in blood 
and their proportion of 
all S. aureus (%)
1995 89 627 2 (0,3)
1996 109 667 0  (0)
1997 120 746 4 (0,5)
1998 189 717 5 (0,7)
1999 211 812 8 (1,0)
2000 261 850 4 (0,5)
2001 340 887 4 (0,5)
2002 601 988 10 (0,9)
2003 859 979 7 (0,7)
2004 1474 1059 33 (3,1)
2005 1379 1013 27 (2,7)
2006 1325 1239 37 (3,0)
2007 1291 1178 32 (2,7)
2008 1739 1259 38 (3,0)
Total 9987 13021 211 (1,6)
Figure 13b. MRSA cases by hospital district, 1995–2008.





	




/""4

+ 04
*5
6+ 65 5
78"
0+" -
0
-
8
9"
8
'-
0
'-
8
29Report 12/2009
National Institute for Health and Welfare
Infectious Diseases in Finland 2008
in Pirkanmaa, and FIN-3 and FIN-3b in 
Pohjois-Karjala. An MRSA strain isolat-
ed from the blood was typed in 31 indi-
viduals. More than half of these were type 
FIN-16, and the rest represented 10 oth-
er strain types. About 60% of the MRSA 
strains in patients 70 years of age or old-
er represented either type FIN-16 or FIN-
10. About 66% of the MRSA strains in 
patients under 15 years of age were type 
FIN-4, type FIN-12, or unique. More 
than 200 strains were tested for the PVL 
gene; these either had been isolated from 
deep foci of infection or represented a 
strain type that might indicate the pres-
ence of PVL genes. Seventy-one strains 
were found to be PVL-positive, and the 
prevailing strain types were FIN-25, FIN-
11, FIN-5b, and FIN-36.
VRE
In 2008, the number of vancomycin-
resistant enterococcus (VRE) ﬁndings 
reported to the NIDR decreased from 
the previous year’s ﬁgure. Most of the 
ﬁndings (24/44) were made in the 
hospital district of Pohjois-Pohjanmaa 
in patients 65 years of age or older. 
In other hospital districts (n=9), the 
number of ﬁndings varied from one to 
six. One VRE case was detected via the 
blood and none through CSF.
In 2008, VRE was typed in 39 
individuals. Over 70% (28/39) of the 
ﬁndings represented the E. faecium 
species and the vanB type. About half of 
the ﬁndings (19/39) were unique ﬁndings 
or individual based on PFGE, and about 
40% (16/39) represented the VRE IV 
strain detected in previous years. The 
rest (n=4) were individual previously 
identiﬁed VRE epidemic strain types. 
Apart from one, all VRE IV strains and 
about one third of unique VRE strains 
were diagnosed in Pohjois-Pohjanmaa. 
ESBL
Since the beginning of 2008, third-
generation Escherichia coli and Klebsiella 
pneumoniae exhibiting reduced 
susceptibility to cephalosporin (I, 
intermediate) or showing resistance to 
cephalosporin (R, resistant) have been 
reported to the NIDR. The majority of 
these bacteria are enzyme-producing 
ESBL strains and extended-spectrum 
cephalosporins that split penicillin. In 
2008, the majority of ESBL bacteria were 
E. coli (1,707) and a small proportion 
Klebsiella pneumoniae (111).
ESBL in E. coli was diagnosed in all 
age groups – almost 80% in women and 
over half from patients aged 65 years or 
more. The majority of cases (88%, or 
1,319/1,707) were diagnosed from the 
urine. Both the number of cases and the 
incidence were highest in the hospital 
district of Helsinki and Uusimaa (almost 
900 cases, 61/100,000).
Forty-two ﬁndings were made 
from the blood, the majority of them 
in the Helsinki and Uusimaa hospital 
district. However, the incidence in blood 
ﬁndings was highest in the hospital 
districts of Länsi-Pohja, Päijät-Häme, 
and Satakunta.
Over half of the ESBL cases reported 
that involved K. pneumoniae were also 
diagnosed in patients aged 65 years or 
more, but the proportion of women 
was smaller, at 60%. The majority of 
diagnoses (64%, 71/111) were made 
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from urine. The number of cases was 
the highest in the hospital district 
of Helsinki and Uusimaa (47/111), 
but the incidence was highest in the 
hospital districts of Central Finland and 
Satakunta. Four ﬁndings were made 
from the blood (4/418, 0.1%).
In 2008, genes encoding extended-
spectrum beta-lactamases were speciﬁed 
in 158 bacterial strains. The strains had 
been collected for epidemic control, re-
search, and conﬁrmation of third-gener-
ation cephalosporin-resistance. The ﬁgure 
includes 130 E. coli and nine K. pneumoni-
ae strains. From the E. coli strains isolated 
in 2008, 95% had an extended-spectrum 
beta-lactamase of the CTX-M group. The 
CTX-M gene breakdown was as follows: 
60% had a CTX-M-1 group ESBL gene, 
39% had a CTX-M-9 group ESBL gene, 
and one per cent had a CTX-M-2 group 
ESBL gene. All K. pneumoniae strains stud-
ied had an extended-spectrum beta-lacta-
mase of some CTX-M group, with the 
CTX-M-1 group being the most common. 
The whole gene sequence, or sequence of 
bases, was speciﬁed for some of the CTX-
M genes. The sequencing of CTX-M genes 
indicated that the CTX-M-15 gene, which 
is common elsewhere in Europe, is found 
in Finland as well.
Invasive pneumococcal 
disease (Streptococcus 
pneumoniae)
There were a record of 924 cases 
(17/100,000) of invasive pneumococcal 
disease reported in 2008. The incidence 
rose from the previous years’ levels (2006–
2007: 14–15/100,000), and, as earlier, 
incidence rates were considerably higher 
in men than in women (20/100,000 v. 
15/100,000). Regional variation was 
signiﬁcant (13–50/100,000), which may 
be due to differences in how actively 
samples were taken. 
The serotype breakdown of 
invasive pneumococcus strains did not 
change from that of 2007. The prevailing 
serotype 14 still covered a ﬁfth of all 
typed strains.
In 2008, the antimicrobial-
susceptibility of 930 pneumococcal strains 
isolated from invasive infections was 
analysed. Compared with 2007, 2008 saw 
the proportion of strains with impaired 
susceptibility to penicillin (MIC  0.125 
μg/ml) increase slightly. The proportion 
of resistant strains (MIC  = 2 mg/L) was 
three per cent, and 15% of the strains had 
reduced susceptibility (I, intermediate) to 
penicillin. The proportion of macrolide-
resistant strains has also increased slightly; 
25% of invasive pneumococcal strains were 
resistant to erythromycin. The proportion 
of multiresistant (PEN-ERY-TET) strains 
was 3.4%, which is slightly lower than in 
2007. In 2008, one levoﬂoxacin-resistant 
(MIC >= 8 mg/L) and two ceftriaxone-
resistant (MIC >= 2 mg/L) strains were 
detected. In general, the changes in the 
susceptibility of invasive pneumococcus 
strains were minor when compared with 
2007 ﬁndings.
Clostridium difﬁcile
Clostridium difﬁcile has been a ﬁnding 
reportable to the NIDR from the 
beginning of 2008. Over 8,000 cases were 
reported, of which 6,275 (118/100,000) 
were of a toxin-producing strain. Almost 
60% of patients diagnosed with C. difﬁcile 
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were women, and half were 75 years of age 
or older. There was signiﬁcant regional 
variation in the incidence rate (57–
189/100,000), with the hospital districts 
of Lappi, Varsinais-Suomi, and Satakunta 
showing the highest incidence. Over 200 
(3%) cases of toxin-positive strains were 
reported in under-15-year-olds, and 
almost 80 of these had been isolated in 
infants under 12 months old. There were 
abundant positive ﬁndings in infants 
in a few hospital districts, and when 
these cases were investigated further, it 
was observed that the majority were of 
patients treated at the outpatient clinic; 
in their case, a positive sample did not 
lead to treatment or further procedures. 
In both adults and children, a C. difﬁcile 
sample should primarily be taken from 
patients suffering from diarrhoea (a stool 
sample), and a patient who has suffered 
from C. difﬁcile before should not be 
automatically tested for C. difﬁcile if the 
symptoms have not recurred. Naturally, 
in infants, evaluating the situation on 
the basis of diarrhoea symptoms may be 
difﬁcult.
In severe cases or when a local out-
break is suspected, clinical laboratories 
have been asked to send C. difﬁcile strains 
for further examination by the THL ref-
erence laboratory. The criteria for send-
ing strains for further study are based on 
European speciﬁcations that are now in 
their draft stage. The number of strains 
sent varied by region: although all hospi-
tal districts reported toxin-positive C. dif-
ﬁcile cases, only 13 of them sent strains for 
genotyping. These came to less than 10% 
of the cases reported to the NIDR. A third 
of the strains studied represented PCR ri-
botype 027, which has been diagnosed in 
seven hospital districts so far: Helsinki and 
Uusimaa, Varsinais-Suomi, Kymenlaakso, 
Satakunta, Etelä-Karjala, Pirkanmaa, and 
Kanta-Häme. Other PCR ribotypes than 
027 also caused severe cases of C. difﬁcile. 
In addition to PCR ribotype 027, other ri-
botypes were detected that may be possi-
ble hyper-producers of toxin. So far, more 
than 70 different PCR ribotypes have 
been detected in Finland, of which about 
30 have been identiﬁed as genotypes pre-
viously reported internationally.
Table 7. Antimicrobial resistance of Streptococcus pneumoniae ﬁndings in blood and CSF, 1998–2008.
Year Cases notiﬁed  
to NIDR
Strains  
examined
Erythromycin 
(%)
Penicillin (I+R) 
(%)
Multidrug 
resistance (%)
1998 561 84 3,6 0 0
1999 568 471 5,9 7,2 0
2000 601 439 8 3,7 1,4
2001 658 360 18,8 7,5 5
2002 599 594 16,3 8 3,7
2003 721 739 21,9 12,7 5,7
2004 748 748 20,5 9,6 3,7
2005 735 731 20,5 9,6 4,4
2006 741 760 27,9 16,4 5,4
2007 788 794 23,2 14,4 
2008 924 930 24,5 17,7 
I – reduced susceptibility; R – resistant; Multidrug resistance – strains simultaneously resistant to 
penicillin, erythromycin and tetracycline.
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Mycobacterial infections
microbiological tests or histology. The 
new grounds for compiling statistics do 
not affect the number of cases based on 
the results of laboratory tests or histology. 
Calculated with these new grounds, 
there were 346 cases of tuberculosis in 
2008, which is a six per cent increase from 
the ﬁgure for 2007 (327). The incidence 
of tuberculosis was 6.5/100,000. In 2008, 
there were 249 cases of tuberculosis con-
ﬁrmed by culture, which is two per cent 
more than in 2007 (245). As judged by 
physicians’ notiﬁcations, 23 patients (7%) 
had a previous history of tuberculosis di-
agnosed after 1950, when anti-tuberculo-
sis medication became available.
Four of the reported cases (1%) 
were diagnosed in under-15-year-
olds, 36 (10%) in those aged 15 to 29 
years, 33 (10%) in 30–44-year-olds, 67 
(19%) in 45–59-year-olds, 91 (26%) 
in 60–74-year-olds, and 115 (33%) in 
people 75 or older.
In 2008, 51 of all reported cases of 
tuberculosis (15%) were diagnosed in 
patients who were born abroad or were 
citizens of other countries. Two (4%) 
of them were under 15 years of age, and 
40 (78%) were 15–44 years old. Thirty-
one cases (61%) were of pulmonary 
tuberculosis, and 22 (39%) presented 
other forms of tuberculosis.
The susceptibility of Mycobacterium 
tuberculosis strains remained good. In 
2008, one multiresistant (MDR, resistant 
at least to isoniazid and rifampicin) M. 
tuberculosis strain was detected. 
In six (2%) of the tuberculosis cases 
reported in 2008, the patient also had an HIV 
Tuberculosis – Mycobacte-
rium tuberculosis
In 2007, Finland introduced the case deﬁ-
nitions of the European Union’s infectious 
disease surveillance, and, at the beginning 
of 2008, the method for calculating num-
bers of tuberculosis cases was changed in 
order to make the compilation of statistics 
on recurring tuberculosis cases more effec-
tive. Consequently, the number of tuber-
culosis cases recorded increased to a slight-
ly higher level than in the preceding years. 
In 2008, tuberculosis treatment outcome 
surveillance based on international spec-
iﬁcations was launched. The ﬁrst reports 
will be included in the next annual report, 
to be published in 2010. Because of the 
complementary data that will improve the 
quality of register data regarding cases in 
outcome surveillance, there will be small 
changes in the number of cases report-
ed to the NIDR for two to three years af-
ter the calendar year in which the case was 
ﬁrst registered. 
In 1995–2006, the registered 
tuberculosis cases included all cases 
conﬁrmed by culture, as reported by the 
laboratories. In addition, cases reported 
by a physician were included only if the 
diagnosis was based on histology or a 
case of pulmonary tuberculosis was 
conﬁrmed by positive sputum staining for 
tuberculosis bacilli. From 2007 onwards, 
the statistics include all cases wherein a 
physician suspected tuberculosis on the 
basis of clinical evidence and decided to 
give full tuberculosis treatment although 
the infection was not conﬁrmed by 
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infection. In all six of these cases, the HIV 
infection was reported as a new case in 2008.
Molecular epidemiology of 
tuberculosis
All new M. tuberculosis strains were 
genotyped in 2008. The typing was 
carried out according to internationally 
harmonised typing methods (spoligotyping 
and MIRU-VNTR typing). Genotyping 
was used to trace the source of infection in 
15 different situations, including 43 cases of 
tuberculosis. 
At the beginning of 2008, a boy who 
was under six months old was diagnosed 
with pulmonary tuberculosis. Despite 
extensive investigation, the source of 
infection could not be determined. In late 
autumn, two new cases of tuberculosis 
with a disease caused by the same genotype 
were diagnosed in Pirkkala. An extensive 
contact investigation showed that these 
new patients had most likely contracted 
the infection at a local restaurant (one 
was a waiter and the other a loyal 
customer). In further investigation, a 
likely source of infection for the outbreak 
was found among loyal customers of the 
same restaurant, which was conﬁrmed by 
genotyping. The source had suffered from 
symptoms for a long time. Because the 
source of infection had been contagious 
for at least a year and a half before being 
diagnosed with tuberculosis, extremely 
extensive contact investigation was 
launched in Pirkkala. The investigation 
also found a link between the ﬁrst case 
diagnosed in a child and the source 
of infection that caused the outbreak. 
New-borns are especially susceptible to 
contracting an infection and the clinical 
disease when exposed to infection. By the 
time of reporting, investigation of the 
outbreak described here had found six 
cases of tuberculosis and a few symptom-
free infected persons.
Year Pulmonary tuberculosis Other 
tuberculosis
All cases
Cases Cases / 
100 000
Cases 
with 
positive 
sputum 
smear
Cases 
with 
positive 
sputum 
smear / 
100 000
 Cases Cases / 
100 000
Cases Cases / 
100 000
Culture-
con-
ﬁrmed 
cases
Proportion 
of culture-
conﬁrmed 
cases (%)
1995 435 8,5 243 4,8 227 4,5 662 13 472 71,3
1996 432 8,4 241 4,7 213 4,2 645 12,6 510 79,1
1997 363 7,1 188 3,7 212 4,1 575 11,2 435 75,7
1998 397 7,7 201 3,9 231 4,5 628 12,2 491 78,2
1999 382 7,4 180 3,5 183 3,5 565 11 487 86,2
2000 370 7,2 227 4,4 167 3,2 537 10,4 451 84
2001 316 6,1 158 3 178 3,4 494 9,5 411 83,2
2002 295 5,7 138 2,7 176 3,4 471 9,1 391 83
2003 291 5,6 148 2,8 121 2,3 471 7,9 347 84,2
2004 230 4,4 127 2,4 102 2 332 6,4 286 86,1
2005 265 5,1 135 2,6 96 1,8 361 6,9 316 87,5
2006 208 4,0 98 1,9 82 1,6 290 5,5 265 91,4
2007 226 4,3 92 1,7 101 1,9 327 6,2 245 74,9
2008 225 4,2 109 2,1 121 2,3 346 6,5 249 72
Table 8. Incidence of tuberculosis in Finland 1995–2008.
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Other infections
vaccination data are investigated for all 
children diagnosed with Hib. 
Meningococcus  
(Neisseria meningitidis)
The number of meningococcus 
infections detected in blood or CSF 
totalled 29, which is clearly less than 
in other recent years. The serogroup 
distribution was the same as before. The 
majority of cases (66%) were caused 
by group B meningococcus. There 
were eight group C strains, and group 
Y meningococcus made two people ill. 
Seven cases were diagnosed in 0–4-year-
olds.
In February–March, two conscripts 
in Kainuu contracted a group B 
meningococcal infection. The typing 
results indicated that the strain was 
the same. No other temporal or local 
clusters were detected.
Table 9. Meningococcal infections by serogroup, 1995–2008.
Year Group A Group B Group C Group Y Group 
W135
Unknown Total
1995 - 50 22 - - 6 78
1996 - 59 15 3 - 2 79
1997 - 36 5 3 - 2 46
1998 - 44 7 2 - 1 54
1999 - 35 9 8 1 5 58
2000 - 30 11 2 3 2 48
2001 - 34 9 4 1 3 51
2002 - 36 6 4 1 2 49
2003 - 28 5 6 - 2 41
2004 - 29 5 4 2 4 44
2005 - 33 1 3 - 3 40
2006 - 38 5 1 - 1 45
2007 - 29 8 5 - 1 43
2008 - 19 8 2 - - 29
Haemophilus 
(Haemophilus inﬂuenzae)
In 2008, there were 45 reported infections 
caused by the Haemophilus inﬂuenzae 
bacterium, diagnosed in blood or CSF. 
Haemophilus inﬂuenzae type b caused an 
infection in two adults and in one child 
a little under two years of age. The child 
had received three doses of Hib vaccine 
in accordance with the vaccination 
programme. The adults were in an age 
group for which this vaccination was 
not yet included in the vaccination 
programme in their childhood. Children 
born in 1985 or later have received 
Hib vaccine at the healthy baby clinic. 
Since the beginning of 2005, under 
the revised vaccination programme, 
Hib vaccination is administered as a 
component of a combination vaccine at 
three, ﬁve, and 12 months. The efﬁciency 
of the vaccination is monitored, and 
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MMR diseases (morbilli, 
parotitis epidemica and 
rubella)
In 2008, the number of measles cases 
reported to the NIDR totalled ﬁve. Four 
of these cases were in foreigners. In 
August, two British children contracted 
measles while vacationing in Finland. A 
large number of young children not yet 
vaccinated against measles were exposed 
to the infection while the Britons visited a 
doctor. This led to extensive investigative 
and preventive measures. A 17-year-
old Swiss woman and a 26-year-old 
Englishman were also diagnosed with 
measles. All foreign patients had arrived 
in Finland right before they fell ill, which 
means they had contracted the infection 
in their home country. The only Finnish 
patient was a 42-year-old woman who 
most likely acquired measles during a 
trip to Thailand.
Five cases of mumps were reported 
in Finland. The patients’ ages ranged 
from 31 to 45 years. Two of them were 
foreigners, and one was born abroad. 
Infections were acquired in Greece, 
Algeria, Thailand, and Tanzania. The 
source of infection of an unvaccinated 
35-year-old Finnish woman remained 
unclear. Not a single case of rubella was 
reported in 2008.
Measles, mumps, and rubella (the 
MMR diseases) are typical children’s 
diseases caused by viruses. Their 
prevention in Finland was initiated 
by launching the MMR vaccination 
programme in 1982. As a result of the 
programme, endemic cases have not 
been diagnosed in Finland since the 
mid-1990s. In the past 10 years, nearly 
all diagnosed MMR cases were acquired 
in a country where MMR diseases still 
commonly occur.
Puumala virus
The number of reported cases of 
Puumala virus reached a record level, 
over 3,200 cases. In each of the previous 
peak years, 2002 and 2005, there were 
about 2,500 cases. The number of cases 
varies, depending on the virus reservoir, 
the size of the bank vole population. The 
variation usually follows a three-year 
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Figure 14. Incidence of Puumala virus by 
hospital district 2008.
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cycle such that two abundant years are 
followed by a quieter year. The frequency 
of epidemic nephropathy is greatest in 
November–December. In 2008, cases 
were being diagnosed more frequently 
already in July. By the beginning of 
November, over 2,000 cases of epidemic 
nephropathy had been diagnosed. 
November and December were the 
peak months, with 658 cases reported 
in December alone. The patients’ age 
and gender distribution was the same as 
before. Of the patients, 58% were men, 
and most patients were of working age. 
There were 165 (5%) under 20 years of 
age. Once again, the rates of incidence 
were highest in the hospital districts of 
Etelä-Savo (297/100,000) and Itä-Savo 
(272/100,000). (Figure 14) 
Tick-borne encephalitis 
(TBE)
Every year since reporting began, 12–
41 cases of TBE have been diagnosed 
in Finland. In 2008, the number of TBE 
cases reported to the NIDR totalled 23, 
of which one was a TBE infection in a 
Swede acquired in Sweden. In 2008, 
people contracted TBE in June–October, 
with July-September being the prime 
time. The patients’ age range was 11 to 
76 years.
Before the vaccination campaign 
that was launched in Åland in 2006, 
about two thirds of the patients were 
from Åland. In 2007, ﬁve people 
contracted TBE on the Åland islands. 
The corresponding ﬁgure in 2008 was 10, 
which increases these cases’ proportion 
from the 25% of the previous year to 
45% of all cases. Two TBE patients living 
on the islands had received appropriate 
vaccinations.
In order to identify the place of 
acquisition, communicable disease 
doctor from the National Institute for 
Health and Welfare interviewed patients 
with TBE diagnosed in 2008 and/or 
studied their patient records. One patient 
had contracted an infection in Simo 
and one in Varkaus, far from the well-
known endemic TBE regions of Isosaari 
in Helsinki, Kokkola, Lappeenranta, 
the Turku archipelago, and Åland. One 
patient contracted TBE either in Simo 
or in the Vaasa-Kokkola archipelago, 
Figure 15. Incidence of borrelia cases by 
hospital district 2008.
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one patient in Isosaari, two vacationers 
in Åland, four in the Turku archipelago, 
and one in Lappeenranta. One Finn 
acquired TBE in EstoniAccording to 
the Swedish Smittskyddsinstitutet, six 
Swedes acquired TBE on the Åland 
islands.
Because of the systematic 
investigation of the place of acquisition, 
Närpiö (in 2007), Varkaus, and Simo 
have been identiﬁed as possible endemic 
TBE regions. This does not change the 
current vaccination recommendations. 
THL continues to identify the place of 
acquisition in the cases diagnosed. 
If a patient falls ill with meningitis 
or encephalitis between May and 
October even though he or she has not 
noticed a tick bite and has not been in 
an identiﬁed endemic TBE region, TBE 
should be suspected.
Tularemia (Francisella 
tularensis)
In 2008, the NIDR received 116 
(2/100,000) notiﬁcations of 
microbiologically conﬁrmed tularemia 
infections. The incidence rate varies 
considerably on the basis of outbreaks 
(0.5–18/100,000). Widespread tularemia 
outbreaks have occurred four times in 
the past 10 years: in 2000 (926 cases), 
2003 (823 cases), 2006 (475 cases), and 
2007 (403 cases). In other years, 100 
cases on average have been reported. The 
majority of the cases were diagnosed in 
the hospital districts of Pohjois-, Keski-, 
and Etelä-Pohjanmaa and in Central 
Finland, all locations where tularemia 
has traditionally been endemic. 
Infections were diagnosed in all age 
groups, most frequently in 30–65-year-
olds. Seventy-three patients (63%) were 
male.
The majority of cases were 
diagnosed between August and October. 
Tularemia is mainly transmitted by 
insect stings. When the infection is 
transmitted from an insect to a human, 
the site of the bite becomes red, swollen, 
and sore, and it develops into an ulcer. 
The infection spreads into local lymph 
glands (ulcero-glandular form). The 
disease may also be transmitted through 
airways or via direct contact with an ill 
animal.
Pogosta disease  
(Sindbis virus)
The number of Pogosta disease cases has 
remained low since 2003. In 2008, there 
were 30 reported cases (0.6/100,000). 
The majority of diagnoses were made 
between August and September. As 
before, the incidence was highest in the 
hospital districts of Itä- and Pohjois-
Savo, Pohjois-Karjala, and Central 
Finland. The patients were 25–78 years 
old (median: 49.5 years), and 57% were 
women.
Extensive Pogosta disease outbreaks 
occur in Finland with seven-year 
intervals (1974, 1981, 1988, and 1995). 
The most recent outbreak was in 2002, 
when nearly 600 cases were reported. 
Outbreaks’ recurrence every seven years 
may be associated with local ecological 
factors and the cyclical variation of 
available animal reservoirs (forest 
game birds) or vectors. Sindbis virus is 
assumed to be transmitted mainly by 
insect stings.
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Borrelia (Lyme disease)
In 2008, the number of borrelia cases 
reported was 1,277, which is about the 
same as in previous years. The incidence 
in the whole country was 24/100,000 
on average, but there was signiﬁcant 
regional variation (Figure 15). Once 
again, the most cases were seen in the 
province of Åland (1,492/100,000), 
accounting for a third of all diagnosed 
borrelia infections in Finland, 403 cases. 
As in previous years, the frequency of 
borrelia was highest in the autumn, from 
August to November. The majority of 
the cases (72%) involved over-45-year-
olds. Fifty-three per cent of the patients 
were female.
Malaria
In 2008, there were 40 diagnoses 
of malaria in Finland. Of these, 33 
were Plasmodium falciparum cases, 
including one P. falciparum + P. vivax 
mixed infection and one P. falciparum 
+ P. malariae mixed infection. The 
remaining cases were ﬁve of P. vivax and 
two of P. ovale. 
The majority of infections (33 
cases, 82%) were acquired in Africa: 29 
were acquired in western Africa and four 
in eastern Africa. Three infections were 
acquired on the Indian subcontinent, 
and four each in South-east Asia and 
Oceania. Twenty-ﬁve patients were 
Finns, and 15 were foreigners. Thirty-
four of the patients were permanent 
residents of Finland, with 20 being native 
Finns who had taken a trip of less than 
six months to a malaria region and four 
being Finns residing in a malaria region. 
Eight patients were immigrants from 
malaria regions who had visited their 
former home. Three were refugees who 
became ill immediately after arriving in 
Finland. Five were visitors to Finland.
The number of malaria cases, the 
countries of acquisition, and the risk 
groups remained approximately the 
same. The total number of malaria cases 
was higher than before because of a 
malaria cluster of 14 Finns travelling to 
Gambia at the end of 2008. The majority 
of the patients who fell ill with malaria 
had used no malaria prophylaxis or had 
used it irregularly. 
Table 10. Malaria cases in Finland in 2008 
by country of acquisition 
Continent Country Cases
Asia Thailand 1
Cambodia 1
Afghanistan 1
India 1
Nepal 1
Total 5
Africa Ghana 4
Nigeria 4
Gambia 14
Sierra Leone 1
Senegal 3
Benin 2
Guinea 1
Kenya 1
Mozambique 1
Sudan 1
Uganda 1
Total 33
Oceania Papua-New-Guinea 1
Vanuatu 1
Total 2
Total 40
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Blood and CSF ﬁndings in 
children
Blood culture ﬁndings in children
There were 590 cases with blood culture 
positive ﬁndings in children under 15 
years of age in 2008, which is about a 
tenth less than in 2004–2007. A little 
over half of the ﬁndings were diagnosed 
in infants under 12 months old.
The microbial breakdown of the 
ﬁndings remained the same: Among 
children under 12 months of age, 
Staphylococcus epidermidis and other 
coagulase-negative staphylococci 
caused over a third of blood culture 
positive infections. The second most 
common cause (15% of the ﬁndings) 
was Streptococcus agalactiae (Group 
B streptococcus, GBS). It is typically 
Table 11. Blood culture ﬁndings 1998–2008, infants (under 1 years of age)
Microbe / Microbial group 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Staphylococcus, other than aureus 57 84 76 99 112 81 146 129 142 131 120
Streptococcus agalactiae 48 42 38 41 46 37 45 73 55 51 49
Escherichia coli 48 39 43 39 40 39 37 41 44 42 38
Staphylococcus aureus 33 29 17 17 24 21 32 32 37 25 23
Streptococcus pneumoniae 17 16 28 19 17 25 28 26 27 21 26
Streptococcus viridans -group 6 10 6 10 8 12 15 12 10 9 8
Enterococcus faecalis 11 7 4 6 11 11 9 15 22 8 5
Enterobacter-species 7 10 6 6 6 6 5 3 13 8 6
Klebsiella-species 8 10 9 8 7 8 9 9 8 6 8
Bacillus 1 - 1 2 - 1 2 2 1 4 4
Other bacteria 41 35 37 22 35 28 36 17 27 28 34
Bacteria, total 277 282 265 269 306 269 364 359 386 333 313
Fungi 3 16 12 11 18 4 3 5 4 4 4
Total number of cases 280 298 277 280 324 273 367 364 390 337 317
Table 12. Blood culture ﬁndings 1998–2008, children (1–14 years)
Microbe / Microbial group 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Streptococcus pneumoniae 60 61 72 76 92 94 88 101 99 114 87
Staphylococcus, other than aureus 34 52 63 44 54 46 34 54 48 51 35
Staphylococcus aureus 48 57 42 35 58 47 58 41 37 42 40
Streptococcus viridans -group 26 19 18 22 12 12 18 24 24 23 21
Streptococcus pyogenes 10 11 9 9 10 12 4 - 9 13 11
Escherichia coli 13 14 20 5 13 13 15 10 16 12 13
Klebsiella-species 3 4 2 2 6 4 5 10 3 6 5
Fusobacterium-species 2 5 4 1 3 - 1 2 3 5 5
Salmonella, other than Typhi 2 4 1 1 1 1 1 1 2 5 2
Enterococcus faecium - - 2 2 4 1 2 2 3 4 2
Other bacteria 53 61 61 48 55 59 44 72 49 53 54
Bacteria, total 251 288 294 245 308 289 270 317 293 328 270
Fungi 3 7 5 1 3 3 1 1 5 4 3
Total number of cases 254 295 299 246 311 292 271 318 298 332 273
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contracted from the mother’s birth 
canal during labour and causes an 
infection in the new-born baby during 
the ﬁrst days of life. Other common 
causes of infection were Escherichia coli, 
Staphylococcus aureus, and Streptococcus 
pneumoniae as expected. Methicillin-
resistant S. aureus strains were not found 
among the reported cases. As in 2007, 
the proportion of enterococci in blood 
ﬁndings in infants was low (2%).
S. pneumoniae was the most 
common ﬁnding in 1–14-year-olds, 
accounting for about a third of the 
reported cases in this age group. It 
was followed by coagulase-negative 
staphylococci, S. aureus, and streptococci 
viridans. One of the reported S. aureus 
cases involved MRSA.
Of all cases reported among 
children under 15 years of age, 
coagulase-negative staphylococci caused 
a little under a third of the blood culture 
positive infections. Infections caused by 
these bacteria were typically healthcare-
associated; predisposing factors include 
a weakened immune system, medical 
procedures, and foreign devices (e.g., 
a central venous catheter). When 
compared with reports for other recent 
years, the children’s blood ﬁndings in 
2008 showed no signiﬁcant changes. 
Fungi constituted only about one per 
cent of the ﬁndings.
Table 13. Cerebrospinal ﬂuid culture ﬁndings 2002–2008, infants (under 1 year of age)
Microbe / Microbial group 2002 2003 2004 2005 2006 2007 2008
Streptococcus agalactiae 5 1 10 7 7 6 3
Streptococcus pneumoniae 3 6 8 3 1 4 3
Staphylococcus, other than aureus 8 4 5 4 3 2 5
Neisseria meningitidis 1 2 4 - 1 2 1
Enterococcus faecalis - 1 1 - 2 1 -
Other bacteria 5 7 9 2 5 4 4
Bacteria, total 22 21 37 16 19 18 16
Fungi - - - - - - -
Total number of cases 22 21 37 16 19 18 16
Table 14. Cerebrospinal ﬂuid culture ﬁndings 2002–2008, children (1–14 years)
Microbe / Microbial group 2002 2003 2004 2005 2006 2007 2008
Neisseria meningitidis 7 4 4 5 7 5 3
Streptococcus pneumoniae 2 10 2 1 5 5 2
Staphylococcus aureus 1 2 2 - - 2 3
Staphylococcus, other than aureus 10 3 6 4 - 1 5
Streptococcus viridans -group - 1 1 - 2 - -
Other bacteria 10 5 4 8 4 - 8
Bacteria, total 30 25 19 18 18 13 21
Fungi - - 1 - - - -
Total number of cases 30 25 20 18 18 13 21
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CSF ﬁndings in children
The number of bacterial and fungal 
ﬁndings related to children’s central 
nervous system infections remained at 
the same level as in the preceding years. 
In 2008, there were a total of 37 reported 
cases, of which 16 were diagnosed in 
infants under 12 months old.
The most common ﬁndings in 
the under-12-month-olds age group 
were coagulase-negative staphylococci 
(5 cases), S. agalactiae (3 cases), and 
pneumococcus (3 cases). Other types of 
ﬁndings involved only single cases.
Unlike in the preceding years, 
coagulase-negative staphylococcus was 
also the most common ﬁnding among 
1–14-year-olds. Meningococcus and S. 
aureus were reported three times and 
Pneumococcus twice. Other types of 
ﬁndings involved isolated cases.
Blood and CSF ﬁndings in 
adults
Blood culture ﬁndings in adults
The total number of blood culture 
ﬁndings in adults has grown steadily and 
is currently almost double that seen in 
1998. In 2008, about 10,000 cases were 
diagnosed, which is 800 cases more 
than in 2007. Gram-positive bacteria 
are still more common in the working-
age population (15–64-year-olds) and 
gram-negative bacteria among those 
aged 65 or more. Anaerobic bacteria 
constituted less than four per cent and 
fungi about two per cent of all blood 
culture positive ﬁndings.
In the working-age population, 
the most common bacterial ﬁnding 
was Escherichia coli, constituting about 
20% of all cases. It was followed by 
Staphylococcus aureus, Streptococcus 
pneumoniae, and coagulase-negative 
staphylococci.
E. coli was also the most common 
blood culture ﬁnding among patients 
aged 65 years or more (accounting 
for a third of all ﬁndings). The next 
most common bacterial ﬁndings 
were S. aureus, coagulase-negative 
staphylococci, Klebsiella species, and S. 
pneumoniae.
Group A streptococci (Streptococcus 
pyogenes) cases continue to increase 
among the working-age population. 
The prevailing emm types have given 
way in part to new, less known types, but 
Table 15. S. pyogenes blood ﬁndings according to emm-type 2004–2008.
Cases notiﬁed to 
NIDR
Strains 
examined
emm1 emm28 emm84 other NT
2004 130 6 (4,6%) 46 (35,4%) 0 (0,0)  72 (55,4%) 6 (4,6%)
2005 113 9 (8,0%) 22 (19,5%) 1 (0,9%) 79 (69,9%) 2 (1,8%)
2006 163 25 (15,3%) 33 (20,2%) 24 (14,7%) 70 (42,9%) 11(6,7%)
2007 205 58 (28,3%) 26 (12,7%) 32 (15,6%) 84 (41,0%) 5 (2,4%)
2008 226 52 (23,0%) 47 (20,8%) 9 (4,0%) 113 (50,0%) 5 (2,2%)
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Table 16. Blood culture ﬁndings 1998–2008, working-age population (15–64 years)
Microbe / Microbial group 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Escherichia coli 495 547 532 613 580 645 707 780 797 838 861
Staphylococcus aureus 340 389 394 437 457 445 486 457 564 544 525
Staphylococcus, other than aureus 319 347 402 406 444 400 421 399 401 407 430
Streptococcus pneumoniae 283 298 310 343 330 406 387 376 346 353 479
Klebsiella-species 106 114 115 114 134 121 159 184 145 159 198
Streptococcus pyogenes 63 81 84 60 93 78 93 76 105 133 157
Streptococcus viridans -group 91 115 117 116 104 121 141 141 130 118 140
Streptococcus, other beta-haemolytic 59 64 59 66 78 79 102 96 127 117 113
Enterococcus faecalis 57 76 67 95 98 84 80 100 83 101 83
Streptococcus agalactiae 55 60 63 76 78 68 64 99 76 83 96
Other bacteria 690 652 686 748 662 681 694 795 802 829 1084
Bacteria, total 2558 2743 2829 3074 3058 3128 3334 3503 3576 3682 3968
Fungi 62 58 56 71 54 80 71 66 80 84 100
Total number of cases 2620 2801 2885 3145 3112 3208 3405 3569 3656 3766 4068
Table 17. Blood culture ﬁndings 1998–2008, aged population (65 years and more)
Microbe / Microbial group 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Escherichia coli 967 1012 1033 1178 1213 1314 1466 1623 1706 1761 1873
Staphylococcus aureus 296 337 397 398 449 466 483 483 601 567 671
Staphylococcus, other than aureus 216 281 349 361 363 343 370 402 395 415 464
Klebsiella-species 177 167 201 241 230 252 342 339 326 340 422
Streptococcus pneumoniae 185 178 189 216 200 241 239 229 270 293 325
Enterococcus faecalis 116 119 143 142 149 146 192 183 202 217 217
Pseudomonas aeruginosa 94 116 119 132 148 148 138 151 154 189 191
Streptococcus, other beta-haemolytic 73 97 87 105 100 123 135 140 174 171 176
Bacteroides fragilis -group 81 99 96 104 96 117 120 135 119 135 146
Enterococcus faecium 41 43 60 61 48 75 96 73 108 129 126
Other bacteria 606 596 677 758 721 774 863 924 965 986 1544
Bacteria, total 2852 3045 3351 3696 3717 3999 4444 4682 5020 5203 5733
Fungi 43 51 68 71 71 113 77 68 76 83 93
Total number of cases 2895 3096 3419 3767 3788 4112 4521 4750 5096 5286 5826
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the emm 1 type (previously T1M1) that 
caused severe illnesses in the past has 
also increased in prevalence. The most 
common emm types of the preceding 
years (emm1 and emm28) still prevail; 
the proportion of the emm84 type 
clearly decreased in 2008. A new type, 
emm119.1, has emerged. The latter was 
the fourth most common type with its 
8% share (Table 19). 
CSF ﬁndings in adults
The number of bacterial and fungal 
ﬁndings in CSF has remained stable in 
the 2000s; in 2008, in total, 150 ﬁndings 
in over-15-year-olds were reported.
Coagulase-negative staphylococcus 
was reported in about a third of the 
cases in working-age patients. The 
most common severe pathogens 
were pneumococcus (18%), S. aureus 
(9%), and meningococcus (2%). The 
proportion of pneumococcus in the 
ﬁndings had clearly increased, and that 
of meningococcus had decreased, when 
compared with 2002–2007 ﬁgures.
In patients aged 65 years or older, 
coagulase-negative staphylococcus 
accounted for one third of the ﬁndings. 
The most commonly reported actual 
pathogens were pneumococcus (18%), S. 
aureus (8%), and Listeria monocytogenes 
(5%); no cases of Enterococcus were 
reported in 2008.
Table 18. Cerebrospinal ﬂuid culture ﬁndings 2002–2008, working-age population (15–64 years) 
Microbe / Microbial group 2002 2003 2004 2005 2006 2007 2008
Staphylococcus, other than aureus 42 28 40 48 44 24 41
Neisseria meningitidis 19 15 11 15 20 16 4
Staphylococcus aureus 6 10 17 10 9 16 13
Streptococcus pneumoniae 18 26 21 15 17 13 26
Pseudomonas, other than 
aeruginosa
6 6 11 5 5 5 4
Other bacteria 44 26 27 47 51 48 53
Bacteria, total 135 111 127 140 146 122 141
Fungi 2 1 6 2 3 6 1
Total number of cases 137 112 133 142 149 128 142
Table 19. Cerebrospinal ﬂuid culture ﬁndings 2002–2008, aged population (65 years and more).
Microbe / Microbial group 2002 2003 2004 2005 2006 2007 2008
Staphylococcus, other than aureus 12 9 11 15 12 14 13
Streptococcus pneumoniae 4 5 4 8 10 4 7
Enterococcus faecalis 2 3 - 2 2 3 -
Staphylococcus aureus 2 7 7 5 3 2 3
Listeria monocytogenes 2 4 2 4 3 2 2
Other bacteria 20 17 13 12 12 7 12
Bacteria, total 42 45 37 46 42 32 37
Fungi 2 - 1 1 2 - 1
Total number of cases 44 45 38 47 44 32 38
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